Xembify Solution
RxNorm Crosswalk NDC 13533-810

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Xembify (NDC 13533-810) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Grifols Usa, Llc's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

5 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection
(RxCUI 2196292)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Xembify 20 % (1 GM in 5 ML) Injection
(RxCUI 2196297)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

10 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection
(RxCUI 2196390)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Xembify 20 % (2 GM in 10 ML) Injection
(RxCUI 2196391)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

20 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection
(RxCUI 2196490)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Xembify 20 % (4 GM in 20 ML) Injection
(RxCUI 2196491)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

50 ML immune globulin subcutaneous (human) - klhw 200 MG/ML Injection
(RxCUI 2196492)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

Xembify 20 % (10 GM in 50 ML) Injection
(RxCUI 2196493)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Xembify

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 13533-810 to RxCUI 2196292, 2196297, 2196390, 2196391, 2196490, 2196491, 2196492, 2196493, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.

* Please review the full disclaimer at the bottom of this page.